Hmm again you guys continuously impress me with the maturity and analysis displayed on here, we really do have threads and calibre of people and posters that is very rarely seen in any other thread/company on HC...
Beaza79, do not at all feel any frustration or disappointment, all of us need to keep coming up with ideas to keep not only us motivated but to research and analyse if we are on the right track. I do see some merits of increasing awareness through social media and there are prob some advantages of having a company rep on there but I also understand the issues you other guys have raised...I myself prob. prefer the status quo but I have little to no representation on social media...don't have the bandwidth, I leave it to others to bring us news from there...my schedule is full just researching and writing...I also know PAR is fully focused on the trials...I too have suggested some ideas in the past but I also understand their current focus and they aren't a large company, yet...resources are precious and this will change as we get bigger and progress.
Yes we are a bit of a different beast to some of the cancer plays...I think my head would be spinning even more if PAR was to be tackling anything cancer related as the biology gets even more complex...
Keep the ideas and suggestions and questions coming ... we all learn lots from it.
- Mozz
- Forums
- ASX - By Stock
- PAR
- Would a PAR representative on social media help??
PAR
paradigm biopharmaceuticals limited..
Add to My Watchlist
1.10%
!
45.0¢

Would a PAR representative on social media help??, page-6
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
45.0¢ |
Change
-0.005(1.10%) |
Mkt cap ! $174.8M |
Open | High | Low | Value | Volume |
45.5¢ | 48.0¢ | 44.0¢ | $500.6K | 1.095M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 17447 | 44.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
45.0¢ | 3140 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 17447 | 0.440 |
4 | 41226 | 0.435 |
6 | 54524 | 0.430 |
5 | 78564 | 0.425 |
1 | 85554 | 0.420 |
Price($) | Vol. | No. |
---|---|---|
0.450 | 3140 | 2 |
0.455 | 2000 | 1 |
0.460 | 8623 | 3 |
0.465 | 17105 | 3 |
0.470 | 2000 | 1 |
Last trade - 14.53pm 04/07/2025 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online